1. Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation
    M. Kovář et al, 2024, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
  2. A novel STAT3/ NFκB p50 axis regulates stromal-KDM2A to promote M2 macrophage-mediated chemoresistance in breast cancer
    Jia-Shing Chen et al, 2023, Cancer Cell International CrossRef